[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339065-105":59,"doc-detail-339065-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","integrated-genomic-and-transcriptomic-analysis-reveals-the-activation-of-pi3k-signaling-pathway-in-hpv-independent-cervical-cancers","Integrated genomic and transcriptomic analysis reveals the activation of PI3K signaling pathway in HPV-independent cervical cancers","","The study investigates HPV-independent cervical cancers (HPV-ind CCs), a comparatively rare subtype with worse outcomes and limited mechanistic understanding. Using RT-PCR, PCR, RNA-seq, whole exome sequencing, and functional testing with the PI3Kα inhibitor BYL719, researchers characterize molecular alterations, clinical correlations, and therapeutic sensitivity. Results identify 25 HPV-ind tumors enriched in older adenocarcinoma patients, show higher tumor mutation burden, and reveal highly activated PI3K/AKT signaling with frequent PIK3CA mutations. Expression profiling separates two prognostic subtypes, highlighting PI3K pathway activation as a key driver and therapeutic target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrated-genomic-and-transcriptomic-analysis-reveals-the-activation-of-pi3k-signaling-pathway-in-hpv-independent-cervical-cancers/339065/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrated-genomic-and-transcriptomic-analysis-reveals-the-activation-of-pi3k-signaling-pathway-in-hpv-independent-cervical-cancers/339065.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What molecular features define HPV-independent cervical cancers in this study?","Question",{"text":112,"@type":113},"HPV-independent cervical cancers show highly activated PI3K/AKT signaling. The most predominant genomic alteration is PIK3CA, along with higher tumor mutation burden and poorer prognosis versus HPV-associated cancers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were HPV status and genomic/transcriptomic data obtained?",{"text":117,"@type":113},"HPV status of 1010 cervical cancer patients was detected using RT-PCR and PCR plus RNA-seq. Whole exome sequencing and RNA-seq were performed on identified HPV-independent cases to map genomic and gene expression landscapes.",{"name":119,"@type":110,"acceptedAnswer":120},"How effective was the PI3Kα inhibitor BYL719 against HPV-independent cancers?",{"text":121,"@type":113},"BYL719 demonstrated superior tumor suppression both in vitro and in vivo, including evidence tested using patient-derived organoids and patient-derived xenografts.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339065,1790124843,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","British Journal of Cancer [www.nature.com/bjc](www.nature.com/bjc)  \nARTICLE OPEN   \nGenetics and Genomics  \nIntegrated genomic and transcriptomic analysis reveals the activation of PI3K signaling pathway in HPV-independent cervical cancers  \nYi Wang 1,2,10, Misi He3,4,5,10, Tiancong He6,10, Xueyan Ouyang 1,2, Xuxia Shen2,7, Wanling Shi1,2, Shengling Huang 2,8, Libing Xiang9, Dongling Zou 3,4,5 ✉, Wei Jiang1,2 ✉ and Huijuan Yang 1,2 ✉  \n© The Author(s) 2024  \n|  |  |  |\n| --- | --- | --- |\n|  | BACKGROUND: HPV-independent cervical cancers (HPV-ind CCs) are uncommon with worse prognosis and poorly understood. This study investigated the molecular characteristics of HPV-ind CCs, aiming to explore new strategies for HPV-ind CCs. METHODS: HPV status of 1010 cervical cancer patients were detected by RT-PCR, PCR and RNA-sequencing (RNA-seq) . Whole exome sequencing (WES) and RNA-seq were performed in identiﬁed HPV-ind CCs. The efﬁcacy of PI3Kα inhibitor BYL719 in HPV-ind CCs was evaluated in cell lines, patient-derived organoids (PDOs) and patient-derived xenografts (PDXs) .\u003Cbr>RESULTS: Twenty-ﬁve CCs were identiﬁed as HPV-ind, which were more common seen in older, adenocarcinoma patients and exhibited poorer prognosis as well as higher tumor mutation burden compared to HPV-associated CCs. HPV-ind CCs were featured with highly activated PI3K/AKT signaling pathway, particularly, PIK3CA being the most predominant genomic alteration (36%) . BYL719 demonstrated superior tumor suppression in vitro and in vivo. Furthermore, HPV-ind CCs were classiﬁed into two subtypes according to distinct prognosis by gene expression proﬁles, the metabolism subtype and immune subtype.\u003Cbr>CONCLUSIONS: This study reveals the prevalence, clinicopathology, and molecular features of HPV-ind CCs and emphasizes the importance of PIK3CA mutations and PI3K pathway activation in tumorigenesis, which suggests the potential signiﬁcance of PI3Kα |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| inhibitors in HPV-ind CC patients. |  |  |\n|  | British Journal of Cancer (2024) 130:987–1000; [https://doi.org/10.1038/s41416-023-02555-w](https://doi.org/10.1038/s41416-023-02555-w) |  |\n|  |  |  |\n\nINTRODUCTION  \nCervical cancers (CCs) are one of the most threatening female reproductive system malignancies worldwide and rank as the fourth most common and cause of cancer death in women, accounting for ~569,000 new cases and 311,000 deaths every year [1, 2] . Human papillomavirus (HPVs) has long been identiﬁed asthe key causative factor for the development of CCs [3, 4] . Once high-risk HPVs have infected cervical basal cells, they express the viral E6 and E7 gene products, which bind to tumor suppressor proteins p53 and pRB, disrupting normal cell cycle regulation, accelerating cell proliferation, and increasing the likelihood of malignant transformation [5] . Current estimates of HPV prevalence in CCs patients vary from 85% to 99% in different cohorts [3, 6–8]; however, with the widespread adoption of CCs screening and endorsement of HPV vaccination [9], the incidence of HPV-  \nassociated CCs (HPV-asso CCs) will predictably decrease. Consequently, it is of importance to understand the mechanism of the occurrence and development of HPV-independent cervical cancers (HPV-ind CCs), which will be helpful to the early diagnosis and treatment.  \nIt is suggested that HPV-ind CCs present a biologically distinct subgroup with different molecular characteristics and poorer prognosis compared to HPV-asso CCs [8, 10, 11] . Nicolás showed a higher proportion of abnormal staining patterns of p53 expression and p16 overexpression in HPV-ind CC [12] . A study from The Cancer Genome Atlas (TCGA) enrolled 9 HPV-ind CCs revealed a higher rate of genomic mutations in KRAS, ARID1A and PTEN [10], suggesting potential driver events in HPV-ind CCs. Other studies have also emphasized the role of long noncoding RNAs (lncRNA","cbCaid30F6RYksaz","https://ap.wps.com/l/cbCaid30F6RYksaz","pdf",4567274,14,"English","# Background\n# Methods\n# Results\n# Conclusions\n# Introduction","[{\"question\":\"What molecular features define HPV-independent cervical cancers in this study?\",\"answer\":\"HPV-independent cervical cancers show highly activated PI3K/AKT signaling. The most predominant genomic alteration is PIK3CA, along with higher tumor mutation burden and poorer prognosis versus HPV-associated cancers.\"},{\"question\":\"How were HPV status and genomic/transcriptomic data obtained?\",\"answer\":\"HPV status of 1010 cervical cancer patients was detected using RT-PCR and PCR plus RNA-seq. Whole exome sequencing and RNA-seq were performed on identified HPV-independent cases to map genomic and gene expression landscapes.\"},{\"question\":\"How effective was the PI3Kα inhibitor BYL719 against HPV-independent cancers?\",\"answer\":\"BYL719 demonstrated superior tumor suppression both in vitro and in vivo, including evidence tested using patient-derived organoids and patient-derived xenografts.\"}]","Integrated genomic and transcriptomic analysis reveals the activation of PI3K signaling pathway in HPV-independent cervical cancers | PDF",1790027666,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8623144b018c35589c32dd46135f62dd.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a58dcd2e8ec72c903ee7d837634d7e83.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1900646bd03d3b31d747381445ea54c2.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/896ceb7c1203ea94e9e3ca5baf4309de.webp",980,1301]